Roche hemophilia drug wins FDA nod, with a warning
ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra, a new medicine for hemophilia A that the Swiss drugmaker is counting on to help to offset eroding sales of older medicines going off patent.
from Reuters: Health News http://ift.tt/2zP9llY
November 16, 2017
|
Labels:
IFTTT,
Reuters: Health News
|
This entry was posted on November 16, 2017
and is filed under
IFTTT
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.